首页> 外国专利> SODIUM ALGINATE CROSSLINKED SLOW-RELEASE MOXIFLOXACIN MICROSPHERE, THE PREPARATION METHOD AND THE USE THEREOF, AND TARGET VASCULAR OCCLUSIVE AGENT OF THE MICROSPHERE

SODIUM ALGINATE CROSSLINKED SLOW-RELEASE MOXIFLOXACIN MICROSPHERE, THE PREPARATION METHOD AND THE USE THEREOF, AND TARGET VASCULAR OCCLUSIVE AGENT OF THE MICROSPHERE

机译:海藻酸钠交联的缓释莫西沙星微球及其制备方法和用途,以及靶向的微球血管阻塞剂

摘要

A sodium alginate crosslinked slow-released moxifloxacin microsphere, the preparation method of the microsphere, a vascular target embolus containing the microsphere and the use of the microsphere in preparing the vascular target embolus. The microsphere contains moxifloxacin, a drug carrier, a adsorbent, a reinforcing agent and a solidifying agent, wherein the drug carrier is sodium alginate, the adsorbent is albumin prepared from human plasma or bovine serum albumin, the reinforcing agent is gelatin or hyaluronic acid, and the solidifying agent is a divalent metal cation chosen from calcium salt or barium salt.
机译:海藻酸钠交联的缓释莫西沙星微球,该微球的制备方法,包含该微球的血管靶标栓剂以及该微球在制备血管靶标栓剂中的用途。微球包含莫西沙星,药物载体,吸附剂,增强剂和固化剂,其中药物载体为海藻酸钠,吸附剂为人血浆或牛血清白蛋白制得的白蛋白,增强剂为明胶或透明质酸,固化剂是选自钙盐或钡盐的二价金属阳离子。

著录项

  • 公开/公告号US2013156827A1

    专利类型

  • 公开/公告日2013-06-20

    原文格式PDF

  • 申请/专利权人 XINJIAN LI;HONG HONG;

    申请/专利号US201013809361

  • 发明设计人 XINJIAN LI;HONG HONG;

    申请日2010-12-30

  • 分类号A61K9/16;

  • 国家 US

  • 入库时间 2022-08-21 16:51:51

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号